MARKET

IART

IART

Integra Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

56.39
+1.47
+2.68%
After Hours: 56.39 0 0.00% 16:00 12/04 EST
OPEN
55.33
PREV CLOSE
54.92
HIGH
56.52
LOW
54.64
VOLUME
235.06K
TURNOVER
--
52 WEEK HIGH
63.23
52 WEEK LOW
34.21
MARKET CAP
4.75B
P/E (TTM)
85.22
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Integra (IART) Up 24% Since Last Earnings Report: Can It Continue?
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 11/27 16:31
Integra LifeSciences Holdings Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / October 28, 2020/ Integra LifeSciences Holdings Corp. (NASDAQ: IART) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on October 28, 2020 at 8:30 AM Eastern Time.
ACCESSWIRE · 10/28 10:30
Integra Lifesciences Q3 Adj. EPS $0.80 Beats $0.53 Estimate, Sales $370.23M Beat $347.98M Estimate
Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.53 by 50.94 percent. This is a 17.65 percent increase over earnings of $0.68 per share
Benzinga · 10/28 10:17
Integra LifeSciences Reports Third Quarter 2020 Financial Results
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2020.
GlobeNewswire · 10/28 10:00
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and the impasse on fiscal stimulus.
Benzinga · 10/25 18:42
Earnings Preview: Integra LifeSciences (IART) Q3 Earnings Expected to Decline
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 10/21 16:32
IART vs. ABMD: Which Stock Is the Better Value Option?
IART vs. ABMD: Which Stock Is the Better Value Option?
Zacks · 10/14 15:40
Integra LifeSciences downgraded to underweight from neutral at J.P. Morgan
IART | Complete Integra LifeSciences Holdings Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
marketwatch.com · 10/08 12:53
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IART. Analyze the recent business situations of Integra Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IART stock price target is 56.92 with a high estimate of 67.00 and a low estimate of 47.00.
EPS
Institutional Holdings
Institutions: 414
Institutional Holdings: 76.51M
% Owned: 90.79%
Shares Outstanding: 84.27M
TypeInstitutionsShares
Increased
83
4.17M
New
70
-1.04M
Decreased
85
2.63M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.48%
Healthcare Equipment & Supplies
+1.33%
Key Executives
Chairman/Independent Director
Stuart Essig
Chief Executive Officer/President/Director
Peter Arduini
Chief Financial Officer/Executive Vice President
Carrie Anderson
Chief Operating Officer/Executive Vice President
Glenn Coleman
Chief Human Resource Officer/Executive Vice President
Lisa Evoli
Executive Vice President/Secretary
Eric Schwartz
Executive Vice President
Robert Davis
Executive Vice President
Michael McBreen
Senior Vice President/Chief Accounting Officer
Jeffrey Mosebrook
Lead Director/Independent Director
Barbara Hill
Independent Director
Rhonda Ballintyn
Independent Director
Keith Bradley
Independent Director
Lloyd Howell
Independent Director
Donald Morel
Independent Director
Raymond Murphy
Independent Director
Christian Schade
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About IART
Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Integra Lifesciences Holdings Corp stock information, including NASDAQ:IART real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IART stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IART stock methods without spending real money on the virtual paper trading platform.